Back to User profile » Prof. Dr. Georgios Panos
Papers published by Prof. Dr. Georgios Panos:
The Therapeutic Approach and Mechanism of Action of Insulin Eye Drops for the Treatment of Neurotrophic Keratitis
Stasik I, Chatzimichail E, Amaxilati E, Konstas PAG, Feltgen N, Panos GD, Gatzioufas Z
Drug Design, Development and Therapy 2026, 20:592266
Published Date: 25 March 2026
Anti-VEGF Agents and the Inner Retina in nAMD: A Narrative Review of RNFL and Ganglion Cell Changes
Tsiropoulos GN, Topouzis F, Amoaku W, Panos GD
Drug Design, Development and Therapy 2026, 20:591127
Published Date: 28 February 2026
Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Chatzimichail E, Christodoulaki E, Konstas PAG, Tsiropoulos GN, Amaxilati E, Gugleta K, Gatzioufas Z, Panos GD
Drug Design, Development and Therapy 2025, 19:2519-2531
Published Date: 2 April 2025
Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Vagiakis I, Papadopoulou EP, Amaxilati E, Tsiropoulos GN, Konstas AG, Panos GD
Drug Design, Development and Therapy 2025, 19:703-714
Published Date: 31 January 2025
Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
Tranos P, Koukoula S, de Politis PB, Tranou M, Giamouridou O, Stavrakas P, Panos GD
Drug Design, Development and Therapy 2024, 18:5367-5375
Published Date: 25 November 2024
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination
Panos LD, Bargiotas P, Hadjigeorgiou G, Panos GD
Drug Design, Development and Therapy 2024, 18:1891-1905
Published Date: 30 May 2024
Revolutionizing Stroke Recovery: Unveiling the Promise of Stem Cell Therapy
Panos LD, Bargiotas P, Arnold M, Hadjigeorgiou G, Panos GD
Drug Design, Development and Therapy 2024, 18:991-1006
Published Date: 29 March 2024
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD
Drug Design, Development and Therapy 2024, 18:365-374
Published Date: 8 February 2024
The Role of Rho Kinase Inhibitors in Corneal Diseases
Futterknecht S, Chatzimichail E, Gugleta K, Panos GD, Gatzioufas Z
Drug Design, Development and Therapy 2024, 18:97-108
Published Date: 19 January 2024
Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies
Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM
Drug Design, Development and Therapy 2023, 17:2861-2873
Published Date: 18 September 2023
Statistical Analysis in Clinical and Experimental Medical Research: Simplified Guidance for Authors and Reviewers
Panos GD, Boeckler FM
Drug Design, Development and Therapy 2023, 17:1959-1961
Published Date: 3 July 2023
Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD
Drug Design, Development and Therapy 2023, 17:961-975
Published Date: 30 March 2023
Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies
Karasavvidou EM, Tranos P, Panos GD
Drug Design, Development and Therapy 2022, 16:2659-2680
Published Date: 9 August 2022
Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges
Massa H, Pipis SY, Adewoyin T, Vergados A, Patra S, Panos GD
Clinical Ophthalmology 2019, 13:1761-1777
Published Date: 10 September 2019
Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
Moschos MM, Nitoda E, Chatziralli IP, Panos GD, Demopoulos CA
Drug Design, Development and Therapy 2016, 10:3977-3981
Published Date: 7 December 2016
Ranibizumab for the treatment of degenerative ocular conditions
Triantafylla M, Massa HF, Dardabounis D, Gatzioufas Z, Kozobolis V, Ioannakis K, Perente I, Panos GD
Clinical Ophthalmology 2014, 8:1187-1198
Published Date: 24 June 2014
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
Panos GD, Gatzioufas Z, Petropoulos IK, Dardabounis D, Thumann G, Hafezi F
Drug Design, Development and Therapy 2013, 7:565-569
Published Date: 10 July 2013
Efficacy of autologous platelets in macular hole surgery
Konstantinidis A, Hero M, Nanos P, Panos GD
Clinical Ophthalmology 2013, 7:745-750
Published Date: 17 April 2013